Reduction of insulin level and dysregulated insulin signaling activity both in diabetic or non-diabetic older individuals diminishes the anabolic capacity of insulin to alleviate MPB in skeletal muscles and may possibly be a primary mechanism shared by age-related sarcopenia and diabetes. This evidence concerns the gene INS and sarcopenia.